Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival.

Transplantation

1 Department of Urology, Northwestern University, Chicago, IL. 2 Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, IL. 3 Comprehensive Transplant Center, Northwestern University, Chicago, IL. 4 Department of Surgery, Northwestern University, Chicago, IL. 5 Columbia Center for Translational Immunology, Columbia University, New York, NY. 6 International Institute for Nanotechnology, Northwestern University, Evanston, IL. 7 Department of Chemistry, Northwestern University, Evanston, IL. 8 Division of Transplantation, Department of Surgery, University of Wisconsin, Madison, WI. 9 Address correspondence to: Dixon B. Kaufman, M.D., Ph.D., Division of Transplantation, Department of Surgery, University of Wisconsin, H5/701 Clinical Sciences Center, 600 Highland Avenue, Madison, WI 53792-7375.

Published: November 2013

Background: The efficiency of islet graft survival after intraportal implantation is compromised by host innate immune responses and the production of proinflammatory cytokines that cause acute cellular injury. This reaction activates intraislet nuclear factor-κB (NF-κB), causing production of gene products that have detrimental effects on β-cell survival and function. We hypothesized that small interfering RNA targeting of IKKβ, a crucial kinase in the NF-κB activation pathway, in islets before transplantation would ameliorate the detrimental effects of cytokines and improve islet survival after transplantation.

Methods: To test this hypothesis, we prepared small interfering RNA-based spherical nucleic acid nanoparticle conjugates targeting IKKβ IKKβ SNA-NCs). We treated isolated islets with IKKβ SNA-NCs and assessed the functional consequences of IKKβ knockdown in vitro and after intraportal transplantation in mice.

Results: Treatment of freshly isolated mouse islets with IKKβ SNA-NCs reduced constitutive IKKβ expression and protected against proinflammatory cytokine-induced NF-κB activation, resulting in improved cell viability and decreased expression of gene products associated with β-cell dysfunction. Intraportal transplantation of a marginal mass (50 islets) of syngeneic islets treated with nanoparticle conjugates targeting IKKβ resulted in reversion to normoglycemia in 50% of streptozotocin-induced diabetic recipients (n=12) compared with 0% of controls (n=12). Histologic analyses showed reduced CD11b(+) cellular infiltration and decreased islet apoptosis.

Conclusions: These results are consistent with the hypothesis that inhibition of intraislet NF-κB activation ameliorates the detrimental effects of host cytokines and demonstrates that preconditioning freshly isolated islets in culture with IKKβ SNA-NCs may be a promising therapy to enhance islet graft function and survival after transplantation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839058PMC
http://dx.doi.org/10.1097/TP.0b013e3182a4190eDOI Listing

Publication Analysis

Top Keywords

ikkβ sna-ncs
16
detrimental effects
12
targeting ikkβ
12
nf-κb activation
12
ikkβ
10
spherical nucleic
8
nucleic acid
8
graft survival
8
islet graft
8
gene products
8

Similar Publications

Proinflammatory cytokines are signaling molecules that are expelled from immune cells like macrophages and other types of cells. Tumor necrosis factor-alpha (TNF-α) is overexpressed during inflammation caused by inflammatory diseases. Therefore, the regulation of TNF-α has a key role in inflammation.

View Article and Find Full Text PDF

Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis.

J Control Release

December 2017

Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

Psoriasis is a T-cell-mediated skin disease with autoimmune nature that is generally not observed in animals, this lack of a relevant experimental animal model of psoriasis has hindered the investigation of pathogenesis of disease. Application and systemic delivery of small interfering RNAs offer many effective therapeutic advantages for gene regulation in the skin. In this study, we present an IMQ animal model of psoriasis and designed a safe fusion peptide carrier, spherical nucleic acid gold nanoparticles conjugate, to improve penetration of the siRNA into the cells and skin and their targeting ability to gene regulation.

View Article and Find Full Text PDF

Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival.

Transplantation

November 2013

1 Department of Urology, Northwestern University, Chicago, IL. 2 Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, IL. 3 Comprehensive Transplant Center, Northwestern University, Chicago, IL. 4 Department of Surgery, Northwestern University, Chicago, IL. 5 Columbia Center for Translational Immunology, Columbia University, New York, NY. 6 International Institute for Nanotechnology, Northwestern University, Evanston, IL. 7 Department of Chemistry, Northwestern University, Evanston, IL. 8 Division of Transplantation, Department of Surgery, University of Wisconsin, Madison, WI. 9 Address correspondence to: Dixon B. Kaufman, M.D., Ph.D., Division of Transplantation, Department of Surgery, University of Wisconsin, H5/701 Clinical Sciences Center, 600 Highland Avenue, Madison, WI 53792-7375.

Background: The efficiency of islet graft survival after intraportal implantation is compromised by host innate immune responses and the production of proinflammatory cytokines that cause acute cellular injury. This reaction activates intraislet nuclear factor-κB (NF-κB), causing production of gene products that have detrimental effects on β-cell survival and function. We hypothesized that small interfering RNA targeting of IKKβ, a crucial kinase in the NF-κB activation pathway, in islets before transplantation would ameliorate the detrimental effects of cytokines and improve islet survival after transplantation.

View Article and Find Full Text PDF

Topical application of nucleic acids offers many potential therapeutic advantages for suppressing genes in the skin, and potentially for systemic gene delivery. However, the epidermal barrier typically precludes entry of gene-suppressing therapy unless the barrier is disrupted. We now show that spherical nucleic acid nanoparticle conjugates (SNA-NCs), gold cores surrounded by a dense shell of highly oriented, covalently immobilized siRNA, freely penetrate almost 100% of keratinocytes in vitro, mouse skin, and human epidermis within hours after application.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!